Contexium

NP39726 Generic and Biosimilar Cancer Medicines

NP39726 Generic and Biosimilar Cancer Medicines is a published development and funding opportunity on Contexium. The donor or funder is The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland). Project location(s): United Kingdom. Applications close on 26 Aug 2026. Budget: 197,026,942 GBP. Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

Opportunity overview

Project name
NP39726 Generic and Biosimilar Cancer Medicines
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) logo
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Donor
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

Key details

Opportunity start date
Opportunity end date
Proposed project start date
Project location(s)
United Kingdom
Budget
197,026,942
Currency
UK Pound Sterling

Summary

Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

Frequently asked questions

What is NP39726 Generic and Biosimilar Cancer Medicines?

NP39726 Generic and Biosimilar Cancer Medicines is a published development and funding opportunity on Contexium. The donor or funder is The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland). Project location(s): United Kingdom. Applications close on 26 Aug 2026. Budget: 197,026,942 GBP. Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

Who is funding NP39726 Generic and Biosimilar Cancer Medicines?

NP39726 Generic and Biosimilar Cancer Medicines is funded by The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland).

When is the deadline to apply for NP39726 Generic and Biosimilar Cancer Medicines?

The application deadline is 26 Aug 2026 12:00 (UTC).

Where will the NP39726 Generic and Biosimilar Cancer Medicines project take place?

The project location(s) are: United Kingdom.

What is the budget for NP39726 Generic and Biosimilar Cancer Medicines?

The available budget is 197,026,942 GBP.

How can I apply for NP39726 Generic and Biosimilar Cancer Medicines?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.